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Background: The incidence and outcome of pts undergoing stent thrombosis (ST) post drug-eluting stents (DES) implantation remains 
controversial. We report the long-term follow-up (FU) of pts with ST post implantation of DES in the real-world clinical practice. 
Methods: The DESIRE Registry is a large, prospective, non-randomized clinical trial evaluating the long-term clinical FU of pts undergoing elective 
or urgent percutaneous coronary intervention (PCI) with DES as the default strategy in a single center. From 05/02 to 02/10, 3,320 pts (4,925 
lesions) were treated with 5,320 DES. Clinical FU was performed at 1, 6 and 12 months, and annually up to 8 years (median = 3,8 years). ST was 
defined according to the Academic Research Consortium criteria. 
Results: During the clinical FU up to 8 years (completed in 98%), the overall incidence of ST was 1.6% (52/3,320), including 34 cases (65%) of 
definite ST (with angiographic confirmation). The mean time from index procedure to the occurrence of definite ST (n=34) was 1.8±1.9 years [10 
cases in the subacute phase (<30 days); 8 cases in the late phase (1-12 months); 16 cases in the very late phase (>1 year)], and the treatment of 
the thrombotic event was: PCI with balloon angioplasty only in 14 cases; PCI with bare metal stent in 8 cases; PCI with DES in 1 case; unsuccessful 
attempt to PCI (unable to successfully cross the lesion with a guidewire and/or restore flow in the target lesion) in 3 cases; coronary artery bypass 
graft surgery in 1 case; thrombolytic therapy in 3 cases, and conservative treatment in 4 cases. In the late clinical follow-up (post ST) (mean time: 
24 months), 56% of patients were asymptomatic, 21% had cardiac death, 9% non-cardiac death, 12% stable angina, and 2% presented with cardiac 
heart failure. In addition, the mean time from ST to cardiac death was 3 months. 
Conclusions: In this subanalysis, pts experiencing definite ST post DES implantation with angiographic confirmation may benefit from reperfusion 
therapy in the majority of cases; however, such event is still associated with relatively high mortality in the long-term follow-up. 
